Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Bahn

Showing results (151-160 of 210) with videos related to

Pageof 21
Sort By:
Brain, Behavior, & Immunity - Health|November 21, 2022
Inflammatory monocyte gene signature predicts beneficial within group effect of simvastatin in patients with schizophrenia spectrum disorders in a secondary analysis of a randomized controlled trialMareike Aichholzer, Shiral S Gangadin, Iris E C Sommer, et al.
Translational Psychiatry|December 19, 2017
Schizophrenia-risk and urban birth are associated with proteomic changes in neonatal dried blood spotsJason D Cooper, Sureyya Ozcan, Renee M Gardner, et al.
The International Journal of Neuropsychopharmacology|June 6, 2014
Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patientsViktoria Stelzhammer, Frieder Haenisch, Man K Chan, et al.
Proteomics|December 14, 2011
Characterization of the human primary visual cortex and cerebellum proteomes using shotgun mass spectrometry-data-independent analysesDaniel Martins-de-Souza, Paul C Guest, Francesca L Guest, et al.
Psychoneuroendocrinology|October 18, 2025
Allostatic load in major depressive disorder: An in-patient clinical studySabine Finlay, Beena Suvarna, Oyelola Adegboye, et al.
Brain, Behavior, and Immunity|November 7, 2015
Pretreatment levels of the fatty acid handling proteins H-FABP and CD36 predict response to olanzapine in recent-onset schizophrenia patientsJakub Tomasik, Emanuel Schwarz, Santiago G Lago, et al.
Plos One|February 2, 2018
Dendritic cell immunotherapy followed by cART interruption during HIV-1 infection induces plasma protein markers of cellular immunity and neutrophil recruitmentHenk-Jan van den Ham, Jason D Cooper, Jakub Tomasik, et al.
Molecular Autism|January 29, 2014
Serum proteomic analysis identifies sex-specific differences in lipid metabolism and inflammation profiles in adults diagnosed with Asperger syndromeHannah Steeb, Jordan M Ramsey, Paul C Guest, et al.
Schizophrenia Research|February 27, 2018
Virus discovery analyses on post-mortem brain tissue and cerebrospinal fluid of schizophrenia patientsJakub Tomasik, Saskia L Smits, F Markus Leweke, et al.
Brain, Behavior, and Immunity|October 9, 2017
Evidence of microglial activation following exposure to serum from first-onset drug-naïve schizophrenia patientsGeertje Frederique van Rees, Santiago Guillermo Lago, David Alan Cox, et al.
Pageof 21

Showing results (151-160 of 210) with videos related to

Sort By:
Pageof 21
Brain, Behavior, & Immunity - Health|November 21, 2022
Inflammatory monocyte gene signature predicts beneficial within group effect of simvastatin in patients with schizophrenia spectrum disorders in a secondary analysis of a randomized controlled trialMareike Aichholzer, Shiral S Gangadin, Iris E C Sommer, et al.
Translational Psychiatry|December 19, 2017
Schizophrenia-risk and urban birth are associated with proteomic changes in neonatal dried blood spotsJason D Cooper, Sureyya Ozcan, Renee M Gardner, et al.
The International Journal of Neuropsychopharmacology|June 6, 2014
Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patientsViktoria Stelzhammer, Frieder Haenisch, Man K Chan, et al.
Proteomics|December 14, 2011
Characterization of the human primary visual cortex and cerebellum proteomes using shotgun mass spectrometry-data-independent analysesDaniel Martins-de-Souza, Paul C Guest, Francesca L Guest, et al.
Psychoneuroendocrinology|October 18, 2025
Allostatic load in major depressive disorder: An in-patient clinical studySabine Finlay, Beena Suvarna, Oyelola Adegboye, et al.
Brain, Behavior, and Immunity|November 7, 2015
Pretreatment levels of the fatty acid handling proteins H-FABP and CD36 predict response to olanzapine in recent-onset schizophrenia patientsJakub Tomasik, Emanuel Schwarz, Santiago G Lago, et al.
Plos One|February 2, 2018
Dendritic cell immunotherapy followed by cART interruption during HIV-1 infection induces plasma protein markers of cellular immunity and neutrophil recruitmentHenk-Jan van den Ham, Jason D Cooper, Jakub Tomasik, et al.
Molecular Autism|January 29, 2014
Serum proteomic analysis identifies sex-specific differences in lipid metabolism and inflammation profiles in adults diagnosed with Asperger syndromeHannah Steeb, Jordan M Ramsey, Paul C Guest, et al.
Schizophrenia Research|February 27, 2018
Virus discovery analyses on post-mortem brain tissue and cerebrospinal fluid of schizophrenia patientsJakub Tomasik, Saskia L Smits, F Markus Leweke, et al.
Brain, Behavior, and Immunity|October 9, 2017
Evidence of microglial activation following exposure to serum from first-onset drug-naïve schizophrenia patientsGeertje Frederique van Rees, Santiago Guillermo Lago, David Alan Cox, et al.
Pageof 21